Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

NCT05694936 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Sodium Valproate
DRUG: Panitumumab
DRUG: Cetuximab

Sponsor

Australasian Gastro-Intestinal Trials Group

Collaborators

[object Object]